Clinical trials

  • seladelpar for Primary biliary cholangitis
  • CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS for Severe multifocal spasticity due to acquired brain damage
  • THIOTEPA for Neuroblastoma | High-risk neuroblastoma
  • (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYLCARBAMOYL)-QUINOLIN-6-YL)(METHYL)AMINO)-PROPYL)PIPERAZIN-1-YL)-2-OXOETHYL)-68GA-[1,4,7,10]-TETRAAZACYCLODODECANE-1,4,7-TRIYL)TRIACETATE for Nonalcoholic steatohepatitis (NASH) | Liver fibrosis
  • TRANEXAMIC ACID for Chronic subdural hematoma
  • Allogeneic natural killer cells (amplified/activated) for Diffuse large B-cell lymphoma | Relapsed/refractory diffuse large B-cell lymphoma
  • ABIRATERONE DECANOATE for Prostate cancer | Advanced prostate cancer
  • OSIMERTINIB MESYLATE for Advanced solid tumors | Non-small cell lung cancer (EGFR-mutant) | Non-small cell lung cancer (EGFR-wildtype)
  • piperacillin sodium, tazobactam sodium for Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae severe infection
  • TAK-360 for Narcolepsy without Cataplexy (NT2)
  • ambroxol hydrochloride; clenbuterol hydrochloride for Parkinson's disease
  • Atezolizumab for Small cell lung cancer | Extensive-stage small cell lung cancer